Literature DB >> 27415777

Techniques and technology evolution of rectal cancer surgery: a history of more than a hundred years.

Marco Maria Lirici1, Cristiano G S Hüscher2.   

Abstract

History of rectal cancer surgery has shown a continuous evolution of techniques and technologies over the years, with the aim of improving both oncological outcomes and patient's quality of life. Progress in rectal cancer surgery depended on a better comprehension of the disease and its behavior, and also, it was strictly linked to advances in technologies and amazing surgical intuitions by some surgeons who pioneered in rectal surgery, and this marked a breakthrough in the surgical treatment of rectal cancer. Rectal surgery with radical intent was first performed by Miles in 1907 and the procedure he developed, abdomino-perineal resection, became a gold standard for many years. In the following years and over the last century other procedures were introduced which became new gold standards: Hartmann's procedure, anterior rectal resection, total mesorectal excision (TME); the last one, developed by Heald in 1982, is the present gold standard treatment of rectal cancer. At the same time, new technologies were developed and introduced into the clinical practice, which enhanced results of surgery and even made possible performing new operations: leg-rests, stapling devices, instruments, appliances and platforms for laparoscopic surgery and transanal rectal surgery. In more recent years the transanal approach to TME has been introduced, which might improve oncologic results of surgery of the rectum. Ongoing randomized studies, future systematic reviews and metanalyses will show whether the transanal approach to TME will become a new gold standard.

Entities:  

Keywords:  Miles procedure; Rectal cancer; anterior rectal resection; laparoscopic rectal resection; rectal cancer surgery; surgical stapler; total mesorectal excision; transanal endoscopic microsurgery; transanal total mesorectal excision

Mesh:

Year:  2016        PMID: 27415777     DOI: 10.1080/13645706.2016.1198381

Source DB:  PubMed          Journal:  Minim Invasive Ther Allied Technol        ISSN: 1364-5706            Impact factor:   2.442


  6 in total

1.  Comparative analysis of modified Bacon operation and double stapler operation in the treatment of rectal cancer.

Authors:  Jianyong Yang; Lijun Tian; Liyun Niu; Chunbao Zhai
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Transanal total mesorectal excision outcomes for advanced rectal cancer in a complex surgical population.

Authors:  Ivy H Gardner; Katherine A Kelley; Walaa F Abdelmoaty; Ahmed Sharata; Amanda V Hayman; Mark H Whiteford
Journal:  Surg Endosc       Date:  2021-01-08       Impact factor: 4.584

3.  Laparoscopic versus conventional open surgery in T4 rectal cancer: A case-control study.

Authors:  Xubing Zhang; Qingbin Wu; Tao Hu; Chaoyang Gu; Liang Bi; Ziqiang Wang
Journal:  J Minim Access Surg       Date:  2019 Jan-Mar       Impact factor: 1.407

4.  Modularized laparoscopic regional en bloc mesogastrium excision (rEME) based on membrane anatomy for distal gastric cancer.

Authors:  Jian Shen; Xiaogang Dong; Zhu Liu; Guoguang Wang; Jing Yang; Fei Zhou; Ming Lu; Xiang Ma; Yuan Li; Chaoyang Tang; Xiagang Luo; Qinghong Zhao; Jianping Zhang
Journal:  Surg Endosc       Date:  2018-07-27       Impact factor: 4.584

5.  Transanal vs laparoscopic total mesorectal excision for rectal cancer: a multicenter randomized phase III clinical trial (TaLaR trial) protocol.

Authors:  Liang Kang; Ziwei Zeng; Shuangling Luo; Hong Zhang; Quan Wang; Mingyang Ren; Miao Wu; Weidong Tong; Qing Xu; Yi Xiao; Aiwen Wu; Yuan-Guang Chen; Bo Feng; Zhanlong Shen; Liang Huang; Xingwei Zhang; Minhua Zheng; Jian-Ping Wang
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-12-14

6.  Endoscopic fenestration in the diagnosis and treatment of delayed anastomotic submucosal abscess: A case report and review of literature.

Authors:  Bao-Zhen Zhang; Yi-Dan Wang; Ye Liao; Jing-Jing Zhang; Yu-Fan Wu; Xiao-Lin Sun; Si-Yu Sun; Jin-Tao Guo
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.